Previous studies have demonstrated that the decreased expression levels of TβRI, SMAD3 and SMAD4 may cause cancer cells to escape the growth inhibition of TGF-β1, and the increased expression of SMAD7 may block the inhibitory effects of TGF-β1. This evidence concerns the gene SMAD3 and cancer.